Cargando…

Causes of Non-Adherence to Allergen-Specific Immunotherapy: A Foundation towards a Patient-Personalized Approach

Background. Allergen-specific immunotherapy (AIT) is the only disease-modifying therapy for allergic conditions, resulting in a long-lasting tolerance beyond the duration of the treatment. Due to the strong relationship between the effectiveness, its optimal duration (at least three years) and the o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ridolo, Erminia, Nicoletta, Francesca, Barone, Alessandro, Ottoni, Martina, Senna, Gianenrico, Canonica, Giorgio Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455852/ https://www.ncbi.nlm.nih.gov/pubmed/37623457 http://dx.doi.org/10.3390/jpm13081206

Ejemplares similares

The Present and Future of Allergen Immunotherapy in Personalized Medicine
por: Ridolo, Erminia, et al.
Publicado: (2022)

Personalized medicine and allergen immunotherapy: the beginning of a new era?
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Safety and adverse reactions in subcutaneous allergen immunotherapy: a review
por: Incorvaia, Cristoforo, et al.
Publicado: (2023)

Factors and co-factors influencing clinical manifestations in nsLTPs allergy: between the good and the bad
por: Ridolo, Erminia, et al.
Publicado: (2023)

Adherence in allergen immunotherapy: Current situation and future implications
por: Gehrt, Francesca, et al.
Publicado: (2022)

Is allergic sensitization relevant in severe asthma? Which allergens may be culprit?
por: Lombardi, Carlo, et al.
Publicado: (2017)

Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Eosinophilic esophagitis: which role for food and inhalant allergens?
por: Ridolo, Erminia, et al.
Publicado: (2012)

Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?
por: Incorvaia, Cristoforo, et al.
Publicado: (2022)

Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence
por: Martignago, Irene, et al.
Publicado: (2017)

Patient’s compliance with allergen immunotherapy
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Patient's Adherence and Compliance and Quality of Life During/After VIT
por: Incorvaia, Cristoforo, et al.
Publicado: (2022)

The intriguing possibility of using probiotics in allergen-specific immunotherapy
por: Furci, Fabiana, et al.
Publicado: (2023)

How to fit allergen immunotherapy in the elderly
por: Ridolo, Erminia, et al.
Publicado: (2017)

AIT (allergen immunotherapy): a model for the “precision medicine”
por: Passalacqua, Giovanni, et al.
Publicado: (2015)

Allergen immunotherapy in asthma; what is new?
por: Passalacqua, Giovanni, et al.
Publicado: (2015)

Long-term effects of allergen sublingual immunotherapy
por: Bozek, Andrzej, et al.
Publicado: (2019)

Adding a biologic to allergen immunotherapy increases treatment efficacy
por: Bożek, Andrzej, et al.
Publicado: (2023)

Bilastine: new insight into antihistamine treatment
por: Ridolo, Erminia, et al.
Publicado: (2015)

Patients with Asthma and Comorbid Allergic Rhinitis: Is Optimal Quality of Life Achievable in Real Life?
por: Braido, Fulvio, et al.
Publicado: (2012)

360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients
por: Canonica, G. Walter, et al.
Publicado: (2015)

Can the Pattern of Early Sensitization to Allergen Molecules Drive a New Approach for Prevention of Allergy?
por: Incorvaia, Cristoforo, et al.
Publicado: (2017)

92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
por: Riccio, Anna Maria, et al.
Publicado: (2012)

The perception of allergen-specific immunotherapy among pediatricians in the primary care setting
por: Landi, Massimo, et al.
Publicado: (2015)

Current treatment strategies for seasonal allergic rhinitis: where are we heading?
por: Ridolo, Erminia, et al.
Publicado: (2022)

The control of allergic rhinitis in real life: a multicenter cross-sectional Italian study
por: Gani, Federica, et al.
Publicado: (2018)

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017)

Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
por: Sahiner, Umit M., et al.
Publicado: (2023)

Effects of Different Up-Dosing Regimens for Hymenoptera Venom Immunotherapy on Serum CTLA-4 and IL-10
por: Riccio, Anna Maria, et al.
Publicado: (2012)

The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners
por: Lombardi, Carlo, et al.
Publicado: (2015)

Physicians’ prescribing behaviour and clinical practice patterns for allergic rhinitis management in Italy
por: Passalacqua, Giovanni, et al.
Publicado: (2020)

Allergen immunotherapy on the way to product-based evaluation—a WAO statement
por: Bachert, Claus, et al.
Publicado: (2015)

Lipid transfer protein syndrome: How to save a life through careful education
por: Ridolo, Erminia, et al.
Publicado: (2022)

Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol
por: Makatsori, Melina, et al.
Publicado: (2015)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

Therapeutic interventions in severe asthma
por: Canonica, Giorgio Walter, et al.
Publicado: (2016)

Allergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?
por: Pucciarini, Francesco, et al.
Publicado: (2022)

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
por: Calderon, Moises A, et al.
Publicado: (2012)

Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy
por: Lee, Ji-Ho, et al.
Publicado: (2019)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fe8l25a299r54h0c0m5iudksmo